Ovation RNA custom nugen technologies, INC.:1164879 [17-003349]
Ended Awarded Last action
- Contract number
- HHSN26400021
- Awardee
-
Tecan Genomics, Inc. UEI R4DEKMG6K8N4
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,452
Award facts
- Contract value 100% obligated
- $8,452.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Carlos, CA 94070, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$4,864 | |
| Original award | $13,316 |
About this award
On May 22, 2017, the National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed-price contract valued at $8,452.00 to Tecan Genomics, Inc. for genomic research technologies and reagents. This contract was issued as a call against Tecan Genomics' existing Blanket Purchase Agreement with the Office of Logistics and Acquisition Operations, a comprehensive $100 million indefinite delivery vehicle through March 31, 2025 that supports biological materials procurement across the National Institutes of Health and Centers for Disease Control and Prevention. The work was performed at the company's location in San Carlos, California, with an ultimate completion date of December 15, 2021. No set-aside designation was applied to this award.
Tecan Genomics, a Switzerland-based manufacturer of life science laboratory automation and detection solutions, has maintained an active federal contracting presence since 2004, delivering specialized scientific equipment and reagents focused on RNA sequencing, genomic analysis, and infectious disease research. The company's broader BPA portfolio demonstrates consistent capability in providing advanced genomic research products, including RNA sequencing kits, methylation analysis systems, targeted genotyping services, and related reagents to multiple NIH institutes and federal research agencies supporting critical genomic and aging research initiatives.
Quick answers
Who was awarded contract HHSN26400021?
HHSN26400021 was awarded to Tecan Genomics, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on May 22, 2017.
How much is contract HHSN26400021 worth?
The government has obligated $8,452 on HHSN26400021.
Is contract HHSN26400021 an order under another contract?
Yes. HHSN26400021 is a BPA call under HHSN263201300006B, a blanket purchase agreement.
Was contract HHSN26400021 competed?
The extent of competition for HHSN26400021 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award